Kåre Schultz
2019
In 2019, Kåre Schultz earned a total compensation of $11.6M as President and Chief Executive Officer at Teva Pharmaceutical Industries, a 64% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,869,720 |
|---|---|
| Salary | $2,000,000 |
| Stock Awards | $5,999,977 |
| Other | $726,867 |
| Total | $11,596,564 |
Schultz received $6M in stock awards, accounting for 52% of the total pay in 2019.
Schultz also received $2.9M in non-equity incentive plan, $2M in salary and $726.9K in other compensation.
Rankings
In 2019, Kåre Schultz's compensation ranked 574th out of 13,971 executives tracked by ExecPay. In other words, Schultz earned more than 95.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 574 out of 13,971 | 96th |
Division Manufacturing | 207 out of 5,692 | 96th |
Major group Chemicals And Allied Products | 53 out of 2,189 | 98th |
Industry group Drugs | 44 out of 1,875 | 98th |
Industry Pharmaceutical Preparations | 37 out of 1,387 | 97th |
Source: SEC filing on April 22, 2020.
Schultz's colleagues
We found six more compensation records of executives who worked with Kåre Schultz at Teva Pharmaceutical Industries in 2019.
2019
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2019
Carlo de Notaristefani
Teva Pharmaceutical Industries
Former Executive Vice President, Global Operations
2019
Michael McClellan
Teva Pharmaceutical Industries
Chief Financial Officer
2019
Brendan O'Grady
Teva Pharmaceutical Industries
Executive Vice President, North America Commercial
2019
Gianfranco Nazzi
Teva Pharmaceutical Industries
Executive Vice President, International Markets Commercial
2019
Eli Kalif
Teva Pharmaceutical Industries
Chief Financial Officer
News
Teva Pharmaceutical Industries CEO Kåre Schultz's 2021 pay slips 7% to $15M
April 13, 2022
Teva Pharmaceutical Industries CEO Kåre Schultz's 2020 pay jumps 36% to $16M
April 21, 2021
Teva Pharmaceutical Industries CEO Kåre Schultz's 2019 pay falls 64% to $12M
April 22, 2020
Teva Pharmaceutical Industries CEO Kåre Schultz's 2018 pay jumps 91% to $32M
April 16, 2019